IDEX executive granted options and shares

Anderson Lisa M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Anderson Lisa M reported acquisition or exercise transactions in this Form 4 filing.

IDEX CORP senior executive Lisa M. Anderson, who serves as SVP, General Counsel, Chief Administrative Officer and Corporate Secretary, reported equity compensation awards. She received options for 5,080 shares of common stock and a grant of 1,205 restricted shares, both at a price of $0.00 per share as part of her compensation.

The restricted shares vest in three substantially equal annual installments starting on February 19, 2027, contingent on her continuous service. The stock options vest in four substantially equal annual installments beginning on the same date, also conditioned on continued service. After these awards, she directly holds 4,327 common shares and 5,080 options.

Insider Trade Summary

Grant/Award: 6,285 shares

Grant/Award 2 txns

Insider Anderson Lisa M

Role SVP, GC, CAO & Corp Sec

Type	Security	Shares	Price	Value
Grant/Award	OPTIONS (RIGHT TO BUY)	5,080	$0.00	$0.00
Grant/Award	COMMON STOCK	1,205	$0.00	$0.00

Holdings After Transaction: OPTIONS (RIGHT TO BUY) — 5,080 contracts (Direct); COMMON STOCK — 4,327 shares (Direct)

Footnotes (2)

1. F1. Represents an award of restricted shares, which vest in three substantially equal annual installments beginning February 19, 2027, subject to the Reporting Person's continuous service through each such date.
2. F2. This option will vest in four substantially equal annual installments beginning February 19, 2027, subject to the Reporting Person's continuous service through each such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did IDEX (IEX) report for Lisa M. Anderson?

Lisa M. Anderson reported receiving a grant of 5,080 stock options and 1,205 restricted common shares. Both awards were granted at $0.00 per share as part of her equity compensation on February 19, 2026, and are subject to time-based vesting conditions.

How do the new equity awards for IDEX (IEX) executive Lisa M. Anderson vest?

The 1,205 restricted shares vest in three substantially equal annual installments beginning February 19, 2027. The 5,080 stock options vest in four substantially equal annual installments starting the same date, in each case requiring her continuous service through the applicable vesting dates.

What is Lisa M. Anderson’s IDEX (IEX) share ownership after these Form 4 awards?

Following the reported transactions, Lisa M. Anderson directly holds 4,327 shares of IDEX common stock and 5,080 options. These holdings reflect the new grants reported on the Form 4, with future exercisability and vesting tied to the disclosed schedules.

Were the IDEX (IEX) equity awards to Lisa M. Anderson open-market purchases?

No, the transactions were coded as grants or awards, not open-market purchases. Both the 5,080 stock options and 1,205 restricted shares were issued at $0.00 per share as part of her compensation package rather than being bought in the market.

What role does Lisa M. Anderson hold at IDEX (IEX) in this Form 4 filing?

Lisa M. Anderson is identified as an officer of IDEX, serving as Senior Vice President, General Counsel, Chief Administrative Officer and Corporate Secretary. The Form 4 reflects equity compensation awarded to her in connection with this executive leadership role.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 09:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anderson Lisa M

(Last) (First) (Middle)

3100 SANDERS ROAD

SUITE 301

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEX CORP /DE/ [ IEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, GC, CAO & Corp Sec

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	02/19/2026		A		1,205(1)	A	$0	4,327	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
OPTIONS (RIGHT TO BUY)	$207.86	02/19/2026		A		5,080		(2)	02/19/2036	COMMON STOCK	5,080	$0	5,080	D

Explanation of Responses:

1. Represents an award of restricted shares, which vest in three substantially equal annual installments beginning February 19, 2027, subject to the Reporting Person's continuous service through each such date.

2. This option will vest in four substantially equal annual installments beginning February 19, 2027, subject to the Reporting Person's continuous service through each such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Sam Rayburn, by Power of Attorney	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.